A soluble endoplasmic reticulum factor as regenerative therapy for Wolfram syndrome

Authors: Mahadevan, Jana, Morikawa, Shuntaro, Yagi, Takuya, Abreu, Damien, Lu, Simin, Kanekura, Kohsuke, Brown, Cris M., Urano, Fumihiko

Source: In Laboratory Investigation September 2020 100(9):1197-1207

A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome

Authors: Lu, Simin, Kanekura, Kohsuke, Hara, Takashi, Mahadevan, Jana, Spears, Larry D., Oslowski, Christine M., Martinez, Rita, Yamazaki-Inoue, Mayu, Toyoda, Masashi, Neilson, Amber, Blanner, Patrick, Brown, Cris M., Semenkovich, Clay F., Marshall, Bess A., Hershey, Tamara, Umezawa, Akihiro, Greer, Peter A., Urano, Fumihiko

Source: Proceedings of the National Academy of Sciences of the United States of America, 2014 Dec 01. 111(49), 17355-17355.

Access URL: https://www.jstor.org/stable/43278680

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

85-LB: A Phase 1b/2 Clinical Trial of Dantrolene Sodium in Patients with Wolfram Syndrome.

Authors: ABREU, DAMIEN, PEARSON, TONI S., BUCELLI, ROBERT C., SIMPSON, ASHLEY, BROWN, CRIS M., KRIES, KELLY, GU, HONGJIE, STONE, STEPHEN I., TYCHSEN, LAWRENCE, STAVERN, GREGORY VAN, WHITE, NEIL H., MARSHALL, BESS A., HERSHEY, TAMARA, URANO, FUMIHIKO

Source: Diabetes; 2019 Supplement, Vol. 68, pN.PAG-N.PAG, 1p

345-LB: Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF): A New Therapeutic Target for Wolfram Syndrome.

Authors: MORIKAWA, SHUNTARO, MAHADEVAN, JANA, YAGI, TAKUYA, ABREU, DAMIEN, KANEKURA, KOHSUKE, BROWN, CRIS M., URANO, FUMIHIKO

Source: Diabetes; 2019 Supplement, Vol. 68, pN.PAG-N.PAG, 1p